Characterization of the modulation of the CYP3A4 activity by Efavirenz

被引：0
|
作者：
Hariparsad, N [1 ]
Nallani, SC [1 ]
Desai, PB [1 ]
机构：
[1] Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
158
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] Effect of hemodialysis on hepatic CYP3A4 activity.
    Nolin, TD
    Appiah, K
    Kendrick, SA
    Le, P
    McMonagle, E
    Himmelfarb, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P23 - P23
  • [32] Resveratrol modulates the catalytic activity of human CYP3A4 and CYP3A5.
    Chang, TKH
    Yeung, KYR
    FASEB JOURNAL, 2000, 14 (08): : A1336 - A1336
  • [33] Role of CYP3A4 in human hepatic diltiazem N-demethylation: Inhibition of CYP3A4 activity by oxidized diltiazem metabolites
    Sutton, D
    Butler, AM
    Nadin, L
    Murray, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (01): : 294 - 300
  • [34] Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone
    Lee, Lucy
    Thoolen, Martin
    Ma, Jiyuan
    Kaushik, Diksha
    Golden, Lee
    Kong, Ronald
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (12): : 1283 - 1290
  • [35] 4β-hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans
    Diczfalusy, Ulf
    Nylen, Hanna
    Elander, Pontus
    Bertilsson, Leif
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) : 183 - 189
  • [36] Modulation of rat hepatic CYP3A4 activity by Brassica oleracea, Hibiscus rosa sinensis, and Tradescantia zebrina
    Han, Chin Jin
    Akowuah, Gabriel Akyirem
    Shukkoor, Mohamed Saleem Abdul
    Biswas, Anupam
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2021, 11 (01): : 7453 - 7459
  • [37] GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
    Quinney, S. K.
    Schwartz, J. B.
    Hall, S. D.
    Gorski, J. C.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S49 - S49
  • [38] CYP3A4*16 and CYP3A4*18 Alleles Found in East Asians Exhibit Differential Catalytic Activities for Seven CYP3A4 Substrate Drugs
    Maekawa, Keiko
    Harakawa, Noriko
    Yoshimura, Takuya
    Kim, Su-Ryang
    Fujimura, Yoshiyuki
    Aohara, Fumika
    Sai, Kimie
    Katori, Noriko
    Tohkin, Masahiro
    Naito, Mikihiko
    Hasegawa, Ryuichi
    Okuda, Haruhiro
    Sawada, Jun-Ichi
    Niwa, Takuro
    Saito, Yoshiro
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (12) : 2100 - 2104
  • [39] Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids
    Kondza, Martin
    Bojic, Mirza
    Tomic, Ivona
    Males, Zeljan
    Rezic, Valentina
    Cavar, Ivan
    MOLECULES, 2021, 26 (10):
  • [40] Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro
    Lin, Qian-meng
    Li, Ying-hui
    Lu, Xiang-ran
    Wang, Ru
    Pang, Ni-hong
    Xu, Ren-ai
    Cai, Jian-ping
    Hu, Guo-xin
    CHEMICAL RESEARCH IN TOXICOLOGY, 2019, 32 (08) : 1583 - 1590
12345